Trial Profile
A double-blind, placebo-controlled study of naltrexone in pyromania.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2019
Price :
$35
*
At a glance
- Drugs Naltrexone (Primary)
- Indications Firesetting behaviour
- Focus Therapeutic Use
- 27 Apr 2010 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 12 Jan 2010 Planned end date changed from 1 Dec 2009 to 1 Aug 2010 as reported by ClinicalTrials.gov.
- 07 Aug 2007 Status changed from initiated to recruiting.